多发性硬化中脑浸润性T-bet表达B细胞的诱导
该研究探讨多发性硬化(MS)中中枢神经系统浸润性B细胞的诱导机制。通过流式细胞术分析MS患者血液、脑脊液和脑组织B细胞趋化因子受体谱,并体外培养B细胞,发现表达CXCR3的B细胞在MS中枢神经系统富集,那他珠单抗可阻止其募集,IFNγ和TLR9信号诱导T-bet高表达IgG1+ B细胞,可能促进CXCR3介导的募集和局部反应。
要点
- CXCR3表达B细胞在MS患者中枢神经系统各腔室富集。
- 那他珠单抗治疗阻止CXCR3high IgG1+亚群募集。
- IFNγ和TLR9信号诱导T-bethigh IgG1+ B细胞,增强跨屏障能力。
核心结论
- T-bethigh IgG1+ B细胞由IFNγ和TLR9信号触发,可能促进MS中枢神经系统CXCR3介导的募集和局部反应。
研究设计与样本
- 研究采用离体流式细胞术评估MS患者(n=10)血液、脑脊液、脑膜和脑组织B细胞的趋化因子受体谱。
- 对未治疗和那他珠单抗治疗的MS患者(n=38)血液中不同记忆亚群进行类似分析。
- 体外培养MS患者(n=21)和健康个体(n=34)的B细胞于Th1和TLR9诱导条件下,并用脑内皮单层确认跨迁移能力。
主要发现
- CXC趋化因子受体3(CXCR3)表达B细胞在MS患者不同中枢神经系统腔室中富集。
- 那他珠单抗治疗阻止CXCR3high IgG1+亚群募集,对应其体外跨中枢神经系统屏障能力增加。
- 阻断干扰素-γ(IFNγ)降低这些细胞的跨迁移潜力和抗原提呈功能。
- IFNγ诱导的MS患者B细胞显示T-bet表达增加和浆母细胞发育。
- 额外TLR9触发进一步上调T-bet和CXCR3,且对IgG1类别转换至关重要。
临床怎么用
- 那他珠单抗可能通过阻止CXCR3high IgG1+ B细胞募集发挥临床效果。
- 靶向IFNγ或TLR9信号可能减少致病性B细胞的中枢神经系统浸润。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Results from anti-CD20 therapies demonstrate that B- and T-cell interaction is a major driver of multiple sclerosis (MS). The local presence of B-cell follicle-like structures and oligoclonal bands in MS patients indicates that certain B cells infiltrate the central nervous system (CNS) to mediate pathology. Which peripheral triggers underlie the development of CNS-infiltrating B cells is not fully understood. METHODS: Ex vivo flow cytometry was used to assess chemokine receptor profiles of B cells in blood, cerebrospinal fluid, meningeal, and brain tissues of MS patients (n = 10). Similar analyses were performed for distinct memory subsets in the blood of untreated and natalizumab-treated MS patients (n = 38). To assess T-bet(CXCR3)+ B-cell differentiation, we cultured B cells from MS patients (n = 21) and healthy individuals (n = 34) under T helper 1- and TLR9-inducing conditions. Their CNS transmigration capacity was confirmed using brain endothelial monolayers. RESULTS: CXC chemokine receptor 3 (CXCR3)-expressing B cells were enriched in different CNS compartments of MS patients. Treatment with the clinically effective drug natalizumab prevented the recruitment of CXCR3high IgG1+ subsets, corresponding to their increased ability to cross CNS barriers in vitro. Blocking of interferon-γ (IFNγ) reduced the transmigration potential and antigen-presenting function of these cells. IFNγ-induced B cells from MS patients showed increased T-bet expression and plasmablast development. Additional TLR9 triggering further upregulated T-bet and CXCR3, and was essential for IgG1 switching. INTERPRETATION: This study demonstrates that T-bethigh IgG1+ B cells are triggered by IFNγ and TLR9 signals, likely contributing to enhanced CXCR3-mediated recruitment and local reactivity in the CNS of MS patients. ANN NEUROL 2019;86:264-278.
引用
- van Langelaar J, Rijvers L, Janssen M, et al. Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis. Ann Neurol. 2019. PMID: 31136008. doi:10.1002/ana.25508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。